9
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Section Review Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis: The pharmaceutical potential of seleno-organic compounds

Pages 861-870 | Published online: 03 Mar 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Michael Parnham & Helmut Sies. (2000) Ebselen: prospective therapy for cerebral ischaemia. Expert Opinion on Investigational Drugs 9:3, pages 607-619.
Read now

Articles from other publishers (4)

Magne O. Sydnes & Minoru Isobe. (2014) Exclusive formation of azo-compounds upon hydrogenolysis of nitrobenzeneseleninic acid derivatives over Pd/C. Monatshefte f?r Chemie - Chemical Monthly 146:2, pages 351-356.
Crossref
Michael J. Parnham & Donatella Verbanac. 2011. Principles of Immunopharmacology. Principles of Immunopharmacology 451 472 .
Violeta Raneva, Hiroyuki Shimasaki, Yumi Furukawa, Nobuo Ueta, Nedyalka Yanishlieva, Jon Erik Aaseng, Vassilia Partali, Hans-Richard Sliwka, Yasukazu Yoshida & Etsuo Niki. (2002) Action of 1-(11-selenadodecyl)-glycerol and 1-(11-selenadodecyl)-3-trolox-glycerol against lipid peroxidation. Lipids 37:7, pages 633-640.
Crossref
N. Yanishlieva, V. Raneva, E. Marinova, H. Houte, V. Partali & H. -R. Sliwka. (2001) 11-selenadodecylglyceryl-1-ether in lipid autoxidation. Journal of the American Oil Chemists' Society 78:7, pages 691.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.